Metropolis IPO: Priced to Leave Limited Upside
We like Metropolis Health Services Limited (MHL IN) ’ track record of growing revenue/patient despite competition, premium pricing and strong...
649 Views
Metropolis Healthcare IPO - Fairly Valued, at Best
Metropolis Health Services Limited (MHL IN) (MHL) plans to raise around US$175m in its Indian IPO via a sell down of shares by the promoter and...
779 Views
Thyrocare Technologies: All’s Not Well with This Wellness Pathology Leader
Thyrocare Technologies (THYROCAR IN) is the fourth largest pathology chain in India and derives 54% of revenues from the wellness/preventive...
574 Views
Dr Lal Pathlabs: Pricing Pressure, Lower Earnings Growth Leave Room for Downside
Dr Lal Pathlabs (DLPL IN) is the largest pathology chain in India and caters to the Rs 600 bn market growing at 15% Cagr. It is strongest in the...
731 Views
Metropolis Healthcare IPO: Stands Apart in Pricing Power, Revenue Growth and Margins
Metropolis Health Services Limited (MHL IN) is the 3rd largest pathology chain in India and caters to the Rs600bn market growing at 15% Cagr. It...
873 Views